Jan 16, 2020
Aniara Diagnostica would like to announce the availability of Biophen Anti-Xa and Biophen Anti-IIa, two-stage Chromogenic Assays
Aug 14, 2019
Heparin Market is Expected to Accumulate Revenues Worth US$16.3 Billion by 2025 - TMR
Jul 08, 2019
XARELTO® (rivaroxaban) Helps Protect Pediatric Patients from Blood Clots in Late-Breaking Phase 3 EINSTEIN-Jr Study
May 31, 2019
Anticoagulants Market, 2024 - Focus on Oral Anticoagulants & Injectable Anticoagulants (Unfractionated Heparin, & Low Molecular Weight Heparin)
May 16, 2019
FDA approves first anticoagulant (blood thinner) for pediatric patients to treat potentially life-threatening blood clots
Jan 22, 2019
Global Anticoagulants Industry
Dec 04, 2018
Perosphere Pharmaceuticals' Ciraparantag Research Presented at American Society of Hematology Annual Meeting
Oct 18, 2018
VERALOX Therapeutics and Frederick Innovative Technology Center, Inc. - Success Story
Jul 10, 2018
Enoxaparin Sodium Market in China 2018: Analysis through 2013 to 2022
Jul 06, 2018
Thrombosis Drugs Market to be Worth US$ 47 Bn by 2026, Says TMR
Feb 13, 2018
GC Pharma and Lee's Pharm Enter into China Licensing Agreement to Develop and Commercialise GCC-4401C, an Investigational Anticoagulant
Dec 15, 2017
Once-Daily Oral Anticoagulant LIXIANA® (edoxaban) Met Primary Endpoint in Investigational Hokusai-VTE CANCER Study
Jun 24, 2017
European Hematology Association: Bleeding or Clotting in Elderly Patients with Cancer-Associated Venous Thromboembolism: Which is Worse?